CytomX Share Price

CytomX Share Price

NASDAQ: CTMX | Micro Cap | Healthcare
$1.93
-$0.02 (-1.03%) Last updated on 19 Nov, 2026 | 01:27 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

CytomX Stock Performance

Open
$2.02
Prev. Close
$1.95
Circuit Range
N/A
Day Range
$1.93 - $2.11
Year Range
$1.91 - $8.20
Volume
1,88,068
Average Traded
$2.02

CytomX Share Price Today

As of 19 November 2026, CytomX Therapeutics, Inc.'s share price is $1.93. The stock opened at $2.02, compared to its previous close of $1.95. During today's trading session, CytomX Therapeutics, Inc.'s share price traded between $1.93 and $2.11, with an average price of $2.02. Over the past 52 weeks, the stock has recorded a high of $8.20 and a low of $1.91. In terms of performance, CytomX Therapeutics, Inc.'s share price has declined by 46.38% over the last six months and is down 54.92% on a year-on-year basis.

CytomX Share Price Chart

Line chart of the CytomX price trend over the selected period. The price fell overall, ranging from 1.93 to 2.11, ending at 1.93.
$1.93$2.11
L
Show Current Price
H

CytomX Stock Fundamentals & Key Indicators

Market Cap
$265.53M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.41
Revenue (TTM)
$76.20B
Return On Equity (TTM)
-31.04%
Profit Margin
-26.73%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
32.23%

CytomX Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.66$10.26$1.42$1.69
Net Profit-$29.51-$18.25-$20.67-$20.00
Net Profit Margin-4471.21%-177.88%-1455.63%-1183.43%
Income ChangeN/A38.16%-13.26%3.24%

CytomX Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$53.16$101.21$138.10$76.20
Net Profit-$99.32-$0.57$31.87-$20.37
Net Profit Margin-186.83%-0.56%23.08%-26.73%
Income ChangeN/A99.43%5691.23%-163.92%

CytomX Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets7.6513.2318.8623.79
Current Assets143.92107.31182.94237.1
Total Assets151.57120.53201.79260.89
Non Current Liabilities5.9435.2293.33194.03
Current Liabilities46.6285.77155.91152.61
Total Liabilities52.56120.99249.24346.64
Shareholders' Equity99.01-0.46-47.45-85.75

CytomX Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-75.59-86.23-56.04-110.79
Investing-59.7499.7-150.6798.26
Financing110.457.5230.230.65

About CytomX

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

CytomX Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$2.36
$1.93
-18.43%
Oct 2026
$2.69
$2.36
-13.08%
Sep 2026
$3.35
$2.71
-20.61%
Aug 2026
$3.09
$3.42
+10.32%
Jul 2026
$3.78
$3.10
-17.33%
Jun 2026
$3.58
$3.75
+4.46%
May 2026
$4.25
$3.59
-14.83%
Apr 2026
$4.73
$4.21
-10.32%
Mar 2026
$5.29
$4.70
-12.23%
Feb 2026
$5.63
$5.36
-6.05%
Jan 2026
$4.27
$5.70
+33.18%
Dec 2025
$4.13
$4.28
+0.23%

CytomX Share Price FAQs